Investors can contact the law firm at no cost to learn more about recovering their losses Attorney Advertising The lawsuit alleges that, during the Class Period, the defendants made false and/or misleading statements and/or failed to disclose important information, including: (1) that Match Group significantly downplayed the challenges facing Tinder, leading to an underestimation of the risk that Tinder's monthly active user count would not recover by the time Match Group released its financial results for ...

Investors can contact the law firm at no cost to learn more about recovering their losses The class action lawsuit against Celsius claims that throughout the relevant period, the company made false or misleading statements and failed to disclose crucial information. Specifically, it is alleged that Celsius materially oversold inventory to PepsiCo, Inc. ("Pepsiâ€Â ), significantly exceeding demand, which set the stage for a future sales decline as Pepsi was expected to sharply reduce its purchases. As Pepsi ...

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons who acquired New York Community Bancorp, Inc. (“NYCB”) common stock in exchange for FlagstarBank N.A. (“Flagstar”) securities in connection with the December 2022 merger between the two companies, charging the combined company, Flagstar Financial, Inc., and certain of its current and former officers and directors with violations of the federal securities laws (collectively, “Defendants”). Investors t ...

NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the "M&A Class Action Firmâ€Â ), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating: Shutterstock, Inc. (NYSE: SSTK), relating to the proposed merger with Getty Images Holdings, Inc. Under the terms of the agreement, Shutterstock stockholders can elect to receiv ...

TORONTO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Guardian Capital LP (the "Managerâ€Â ) today announced that it will terminate GuardPath Managed Decumulation 2042 Fund (the "Decumulation Fundâ€Â ) and GuardPath Modern Tontine 2042 Trust (the "Tontine Trustâ€Â , and together with the Decumulation Fund, the "Fundsâ€Â ) effective on or about March 28, 2025 (the "Termination Dateâ€Â ). Effective immediately, no further direct subscriptions of mutual fund units or ETF units of the Funds will be accepted, including swi ...

TORONTO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Guardian Capital LP announces that commencing in January 2025, the distribution frequency for the Guardian Capital funds listed below (the "Fundsâ€Â ) will increase from quarterly to monthly. | Guardian Capital Fund | Series of Units | | --- | --- | | GC One Fixed Income Portfolio | Mutual Fund Units: Series A, Series F and Series I | | Guardian Canadian Bond Fund | ETF Units (TSX: GCBD) | | | Mutual Fund Units: Series A, Series F and Series I | | Guardian Investme ...

MIAMI, Jan. 10, 2025 /PRNewswire/ -- Lennar Corporation (NYSE: LEN and LEN.B) ("Lennar") announced that its Board of Directors has declared a dividend and set the date for the previously announced taxable spin-off of approximately 80% of the stock of Millrose Properties, Inc. ("Millrose"). Stuart Miller, Executive Chairman and Co-Chief Executive Officer of Lennar, said, "We are very pleased to announce another milestone towards completing the successful spin-off of Millrose. This spin-off is a significant s ...

SAN DIEGO, Jan. 10, 2025 /PRNewswire/ -- Expert Systems, a hybrid AI enabled drug discovery and development accelerator, announced a significant milestone in a development of Traws Pharma, Inc. 's (NASDAQ: TRAW) H5N1 antiviral program. The investigational drug, Tivoxavir Marboxil, has shown encouraging results as a single-dose treatment for H5N1 avian influenza, representing a potentially pivotal advance in addressing this serious health challenge. ​​Expert Systems and Traws Pharma Report Breakthrough in ...

SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) (“Regeneron” or the “Company”) common stock between November 2, 2023 and October 30, 2024 (the “Class Period”), charging the Company and certain of its current and former senior executives with violations of the federal securities laws (collectively, “Defendants”). Regeneron investors have until March 10, ...

TORONTO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that at December 31, 2024, its unaudited net asset value per share (“NAV”) was $0.76. This announcement is made based on ThreeD’s established practice of releasing NAV on a monthly basis as part of the Company’s ongoing response to shareh ...